The role of amyloid in the pathogenesis of Alzheimer's disease

Biological Chemistry

Volumn 378, Issue 9, 1997, Pages 937-950

  Verbeek, Marcel M ^a   Ruiter, Dirk J ^a   De Waal, Robert M W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid protein; Congophilic angiopathy; Inflammation; Risk factors; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; CARBOXY TERMINAL SEQUENCE; CEREBROVASCULAR DISEASE; HUMAN; INFLAMMATION; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; SENILE PLAQUE; VASCULAR SMOOTH MUSCLE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SENILE PLAQUES;

EID: 0030778933     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Abraham, C.R., Selkoe, D.J., and Potter, H. (1988). Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Akiyama, H., and McGeer, P.L. (1990). Brain microglia constitutively express β-2 integrins. J. Neuroimmunol. 30, 81-93.
3. Arriagada, P.V. Growdown, J.H., Hedley-Whyte, E.T., and Hyman, B.T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42, 631-639.
4. Bahmanyar, S., Higgins, G.A., Goldgaber, D., Lewis, D.A., Morrison, J.H., Wilson, M.C., Shankar, S.K., and Gajdusek, D.C. (1987). Localization of amyloid β protein messenger RNA in brains from patients with Alzheimer's disease. Science 237, 77-80.
5. Barrow, C.J., and Zagorski, M.G. (1991). Solution structures of β peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179-182.
6. Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., Slunt, H.H., Wang, R., Seeger, M., Levey, A.I., Gandy, S.E., Copeland, N.G., Jenkins, N.A., Price, D.L., Younkin, S.G., and Sisodia, S.S. (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1 - 42/1 - 40 ration in vitro and in vivo. Neuron. 77, 1005-1013.
7. Breitner, J.C.S. (1996). The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47, 401-411.
8. Busciglio, J., Gabuzda, D.H., Matsudaira, P., and Yankner, B.A. (1993). Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 90, 2092-2096.
9. Canning, D.R., McKeon, R.J., DeWitt, D.A., Perry, G., Wujek, J.R., Frederickson, R.C.A., and Silver, J. (1993). β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124, 289-298.
10. Caporaso, G.L., Gandy, S.E., Buxbaum, J.D., and Greengard, P. (1992). Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 2252-2256.
11. Chartier-Harlin, M., Crawford, F., Houldon, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., and Mullan, M. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353, 844-846.
12. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y. Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D.J. (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672-674.
13. Citron, M., Westaway, D., Xia, W.M., Carlson, G., Diehl, T., Levesque, G., Johnsonwood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, R. Hyslop, P.S., and Selkoe, D.J. (1997). Mutant presenilins of Alzheimer's disease increase production of 42 residue amyloid beta protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72.
14. Clemens, J.A., and Stephenson, D.T. (1992). Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging 13, 581-586.
15. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell. P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
16. Corder, E.H., Saunders, A.M., Risch, N.J., Strittmatter, W.J., Schmechel, D.E., Gaskell, J.P.C., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180-183.
17. Cummings, B.J., Pike, C.J., Shankle, W.R., and Cotman, C.W. (1996). Beta amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17, 921-933.
18. Davis, J., and Van Nostrand, W.E. (1996). Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc. Natl. Acad. Sci. USA 93, 2996-3000.
19. Davis-Salinas, J., and Van Nostrand, W.E. (1995). Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270, 20887-20890.
20. Davis-Salinas, J., Saporito-Irwin, S.M., Cotman, C.W., and Van Nostrand, W.E. (1995). Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934.
21. Duong, T., Pommier, E.G., and Schiebel, A.B. (1989). Immunodetection of the amyloid P component in Alzheimer's disease. Acta. Neuropathol. 78, 429-437.
22. Dyrks, T., Mönning, U., Beyreuther, K., and Turner, J. (1994). Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusive. FEBS Letters. 349, 210-214.
23. Eikelenboom, P., and Stam, F.C. (1982). Immunoglobulins and complement factors in senile plaques. An immunohistochemical study. Acta. Neuropathol. 57, 239-242.
24. Eikelenboom, P., and Veerhuis, R. (1996). The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17, 673-680.
25. Esch, F.S., Keim, P.S., Beattie, E.C., Blacher, R.W., Culwell, A.R., Oltersdorf, T., McClure, D., and Ward, P.J. (1990). Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248, 1122-1124.
26. Frackowiak, J., Zoltowska, A., and Wisniewski, H.M. (1994). Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 53, 637-645.
27. Fraser, P.E., Nguyen, J.T., McLachlan, D.R., Abraham, C.R., and Kirschner, D.A. (1993). α1-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 61, 298-305.
28. Fukuchi, K., Ho, L., Younkin, S.G., Kunkel, D.D., Ogburn, C.E., LeBoeuf, R.C., Furlong, C.E., Deeb, S.S., Nochlin, D., Wegiel, J., Wisniewski, H.M., and Martin, G.M. (1997). High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am. J. Pathol. 149, 219-227.
29. Games, D., Khan, K.M., Soriano, F.G., Keim, P.S., Davis, P.L., Bryant, K., and Lieberburg, I. (1992). Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol. Aging 13, 569-576.
30. Games, D., Adams, D., Alessandri, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D.B., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
31. Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N.H., Tomita, M., Wisniewski, T., and Frangione, B. (1993). The cerebrospinal-fluid solubleform of Alzheimer's amyloid beta is complexed to SP40,40 (apolipoprotein J), an inhibitor of the compement membrane attack complex. Biochem. J. 293, 27-30.
32. Glenner, G.G., and Wong, C.W. (1984). Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
33. Goate, A., Chartier-Harlin, M., Mullan, M., Brown, J., Crawford, F. Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., and Hardy, J. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
34. Goldgaber, D., Harris, H.W., Hla, T., Maciag, T., Donnelly, R.J., Jacobson, S.J., Vitek, M.P., and Gajdusek, D.C. (1989). Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
35. Graham, D.I., Gentleman, S.M., Lynch, A., and Roberts, G.W. (1995). Distribution of β-amyloid protein in the brain following severe head injury. Neuropathol. Appl. Neurobiol. 21, 27-34.
36. Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L., Jr., Younkin, L.H., Suzuki, N., and Younkin, S.G. (1995). Amyloid β protein (Aβ) in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7016.
37. Greenberg, S.M., Rebeck, G.W., Vonsattel, J.-P., Gomez-Isla, T., and Hyman, B.T. (1995). Apolipoprotein E ∈ 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38, 254-259.
38. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perror, L.J., White III, C.L., and Araoz, C. (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
39. Haan, J., Lanser, J.B.K., Zijderveld, I., van der Does, I.G.F., and Roos, R.A.C. (1990). Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Arch. Neurol. 965, 967.
40. Haan, J., Bakker, E., Jennekens-Schinkel, A., and Roos, R.A.C. (1992). Progressive dementia, without cerebral hemorrhage, in a patient with hereditary cerebral amyloid angiopathy. Clin. Neurol. Neurosurg. 94, 317-318.
41. Haass, C., Hung, A.Y., and Selkoe, D.J. (1991). Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J. Neurosci. 11, 3783-3793.
42. Haass, C., Koo, E.H., Mellon, A., Hung, A.Y., and Selkoe, D.J. (1992). Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
43. Haass, C., Hung, A.Y., Schlossmacher, M.G., Teplow, D.B., and Selkoe, D.J. (1993). β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
44. Haass, C., Hung, A.Y., Selkoe, D.J., and Teplow, D.B. (1994). Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
45. Haga, S., Akai, K., and Ishii, T. (1989). Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. Acta. Neuropathol. 77, 569-575.
46. Henderson, A.S., Easteal, S., Jorm, A.F., MacKinnon, A.J., Korten, A.E., Christensen, H., Croft, L., and Jacomb, P.A. (1995). Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346, 1387-1390.
47. Hendriks, L., van Duijn, C.M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., Mclnnis, M.G., Atonarakis, S.E., Martin, J.-J., Hofman, A., and Van Broeckhoven, C. (1992). Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nature Genet. 1, 218-221.
48. Hofman, A., Ott, A., Breteler, M.M.B., Bots, M.L., Slooter, A.J.C., van Harskamp, F., van Duijn, C.M., Van Broeckhoven, C., and Grobbee, D.E. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
49. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S.G., Yang, F., and Cole, G. (1996). Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
50. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994). Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53.
51. Iwatsubo, T., Mann, D.M.A., Odaka, A., Suzuki, N., and Ihara, Y. (1995). Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37, 294-299.
52. Iwatsubo, T., Saldo, T.C., Mann, D.M.A., Lee, V.M.-Y., and Trojanowski, J.Q. (1996). Full-length amyloid-β(1-42(43) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am. J. Pathol. 149, 1823-1830.
53. Jarrett, J.T., Berger, E.P., and Lansbury, P.T. (1993). The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
54. Kalaria, R.N., and Kroon, S.N. (1992). Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem. Biophys. Res. Commun. 186, 461-466.
55. Kang, J., Lemaire, H., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K., Multhaup, G., Beyreuther, K., and Müller-Hill, B. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
56. Kawai, M., Kalaria, R.N., Cras, P., Siedlak, S.L., Velasco, M.E., Shelton, E.R., Chan, H.W., Greenberg, B., and Perry, G. (1993). Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res. 623, 142-146.
57. Kimura, T., Hashimura, T., and Miyakawa, T. (1991). Observations of microvessels in the brain with Alzheimer's disease by the scanning electron microscope. Jpn. J. Psychiatr. Neurol. 45, 671-676.
58. Knops, J., Lieberburg, I., and Sinha, S. (1992). Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells. J. Biol. Chem. 267, 16022-16024.
59. Koo, E.H., and Squazzo, S.L. (1994). Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
60. Koudinov, A., Matsubara, E., Frangione, B., and Ghiso, J. (1994). The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem. Biophys. Res. Commun. 205, 1164-1171.
61. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K., and Yankner, B.A. (1991). An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88, 7247-7251.
62. Lemere, C.A., Lopera, F., Kosik, K.S., Lendon, C.L., Ossa, J., Saldo, T.C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., Hincapie, L., Arango, J.L., Anthony, D.C., Koo, E.H., Goate, A., Selkoe, D.J., and Arango, J.C. (1996). The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2, 1146-1150.
63. Levy, E., Carman, M.D., Fernandez-Madrid, I.J., Power, M.D., Lieberburg, I., van Duinen, S.G., Bots, G.T.A.M., Luyendijk, W., and Frangione, B. (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248, 1124-1126.
64. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C., Jondro, P.D., Schmidt, S.D., Wang, K., Crowley, A.C., Fu, Y-H., Guenette, S.Y., Galas, D., Nemens, E., Wijsman, E.M., Bird, T.D., Schellenberg, G.D., and Tanzi, R.E. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269, 973-977.
65. Lorenzo, A., and Yankner, B.A. (1994). β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
66. Lucotte, G., Turpin, J.-C., and Landais, P. (1994). Apolipoprotein E-e 4 allele doses in late-onset Alzheimer's disease. Ann. Neurol. 36, 681-682.
67. Luyendijk, W., Bots, G.T.A.M., Vegter-van der Vlis, M., Went, L.N., and Frangione, B. (1988). Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy. J. Neurol. Sci. 85, 267-280.
68. Ma, J., Yee, A., Brewer, B.J., Das, S., and Potter, H. (1994). Amyloid associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
69. Maat-Schieman, M.L.C., Rozemuller, A.J., van Duinen, S.G., Haan, J., Eikelenboom, P., and Roos, R.A.C. (1994). Microglia in diffuse plaques in Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch). An immunohistochemical study. J. Neuropathol. Exp. Neurol. 53, 483-491.
70. Mackenzie, I.R.A. (1994). Senile plaques do not progressively accumulate with normal aging. Acta. Neuropathol. 87, 520-525.
71. Mandybur, T.I. (1975). The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25, 120-126.
72. Mann, D.M.A., Younis, N., Jones, D., and Stoddart, R.W. (1992). The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1, 201-215.
73. 42(43). Ann. Neurol. 40, 149-156.
74. 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am. J. Pathol. 148, 1257-1266.
75. Mann, D.M.A., Iwatsubo, T., Nochlin, D., Sumi, S.M., Levy-Lahad, E., and Bird, T.D. (1997). Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: The Volga German families. Ann. Neurol. 41, 52-57.
76. Martin, L.J., Pardo, C.A., Cork, L.C., and Price, D.L (1994). Synaptic pathology and glial responses to neural injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381.
77. Mayeux, R., Ottman, R., Tang, M.-X., Noboa-Bauza, L., Marder, K., Gurland, B., and Stern, Y. (1993). Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first degree relatives. Ann. Neurol. 33, 494-501.
78. McGeer, P.L., Kawamata, T., and Walker, D.G. (1992). Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579, 337-341.
79. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, L.J., Baron, P., Villalba, M., Ferrari, D., and Rossi, F. (1995). Activation of microglial cells by β-amyloid protein and Interferon-γ. Nature 374, 647-650.
80. Mullan, M., Crawford, F., Axelman, K., Houldon, H., Lilius, L., Winblad, B., and Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1, 345-347.
81. Murphy, G.M.J., Forno, L.S., Higgins, L., Scardina, J.M., Eng, F.L., and Cordell, B. (1994). Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am. J. Pathol. 144, 1082-1088.
82. Murrell, J., Farlow, M., Ghetti, B., and Benson, M.D. (1991). A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
83. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res. 541, 163-166.
84. Narindrasorasak, S., Altman, R.A., Gonzalez-DeWhitt, P., Greenberg, B.D., and Kisilevsky, R. (1995). An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72, 272-282.
85. Nicoll, J.A.R., Roberts, G.W., and Graham, D.I. (1995). Apolipoprotein E ∈ 4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137.
86. Palmert, M.R., Golde, T.E., Cohen, M.L., Kovacs, D.M., Tanzi, R.E., Gusella, J.F., Usiak, M.F., Younkin, L.H., and Younkin, S.G. (1988). Amyloid protein precursor messenger RNAs: Differential expression in Alzheimer's disease. Science 241, 1080-1084.
87. Pasternack, J.M., Abraham, C.R., Van Dyke, B.J., Potter, H., and Younkin, S.G. (1989). Astrocytes in Alzheimer's disease gray matter express α1-antichymotrypsin mRNA. Am. J. Pathol. 135, 827-834.
88. Perlmutter, L.S., Barrón, E., Saperia, D., and Chui, H.C. (1991). Association between vascular basement membrane components and the lesions of Alzheimer's disease. J. Neurosci. Res. 30, 673-681.
89. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., and Cotman, C.W. (1993). Neurodogeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neuro-sci. 13, 1676-1687.
90. Ponte, P., Gonzalez-DeWhitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Wallace, W., Lieberburg, I., Fuller, F., and Cordell, B. (1988). A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331, 525-532.
91. Premkumar, D.R.D., Cohen, D.L., Hedera, P., Friedland, R.P., and Kalaria, R.N. (1996). Apolipoprotein E-∈ 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148, 2083-2095.
92. Roberts, G.W. (1988). Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: evidence for common genesis. Lancet 11, 1456-1458.
93. Roberts, G.W., Allsop, D., and Bruton, C. (1990). The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry 53, 373-378.
94. Roberts, G.W., Gentleman, S.M., Lynch, A., and Graham, D.I. (1991). βA4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423.
95. Rogers, J., Cooper, N.R., Webster, S., Schultz, J., McGeer, P.L., Styren, S.D., Civin, W.H., Brachova, L., Bradt, C., Ward, P., and Lieberburg, I. (1992). Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
96. Rozemuller, J.M., Eikelenboom, P., Pals, S.T., and Stam, F.C. (1989a). Microglial cells around amyloid plaques in Alzheimer's disease express leukocyte adhesion molecules of the LFA-1 family. Neurosci. Lett. 101, 288-292.
97. Rozemuller, J.M., Eikelenboom, P., Stam, F.C., Beyreuther, K., and Masters, C.L. (1989b). A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48, 674-691.
98. Rozemuller, J.M., Abbink, J.J., Kamp, A.M., Stam, F.C., Hack, C.E., and Eikelenboom, P. (1991). Distribution pattern and functional state of α1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. Acta. Neuropathol. 82, 200-207.
99. Rozemuller, A.J.M., Roos, R.A.C., Bots, G.T.A.M., Kamphorst, W., Eikelenboom, P., and Van Nostrand, W.E. (1993). Distribution of β/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am. J. Pathol. 142, 1449-1457.
100. Sambamurti, K., Shioi, J., Anderson, J.P., Pappolla, M.A., and Robakis, N.K. (1992). Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J. Neurosci. Res. 33, 319-329.
101. Sanan, D.A., Weisgraber, K.H., Russell, S.J., Mahley, R.W., Huang, D., Saunders, A., Schemel, D., Wisniewski, T., Frangione, B., Roses, A.D., and Strittmatter, W.J. (1994). Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860-869.
102. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A.D. (1993). Association of apolipoprotein E allele ∈ 4 with late-onset familial sporadic Alzheimer's disease. Neurology 43, 1467-1472.
103. 42 in cerebrovascular deposits. Amyloid: Int. J. Exp. Clin. Invest. 2, 234-240.
104. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G.D., Tanzi, R.E., Wasco, W., Lannfelt, L., Sekoe, D.J., and Younkin, S.G. (1996). Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870.
105. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., and Roses, A.D. (1993). Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
106. Scott, S.A., Johnson, S.A., Zarow, C., and Perlmutter, L.S. (1993). Inability to detect beta-amyloid protein precursor mRNA in Alzheimer plaque-associated microglia. Exp. Neurol. 121, 113-118.
107. Selkoe, D.J. (1991). The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
108. Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
109. Shaffer, L.M., Dority, M.D., Gupta-Bansal, R., Frederickson, R.C.A., Younkin, S.G., and Brunden, K.R. (1995). Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
110. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A.R., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M., and St.George-Hyslop, P.H. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
111. Shoji, M., Hirai, S., Harigaya, Y., Kawarabayashi, T., and Yamaguchi, H. (1990a). The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res. 530, 113-116.
112. Shoji, M., Hirai, S., Yamaguchi, H., Harigaya, Y., and Kawarabayashi, T. (1990b). Amyloid β-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia. Brain Res. 512, 164-168.
113. Shoji, M., Hirai, S., Yamaguchi, H., Harigaya, Y., Ishiguro, K., and Matsubara, E. (1991). Alpha 1-antichymotrypsin is present in diffuse senile plaques. Am. J. Pathol. 138, 247-257.
114. Shoji, M., Golde, T.E., Ghiso, J., Cheung, T.T., Estus, S., Shaffer, L.M., Cai, X.-D., McKay, D.M., Tintner, R., Frangione, B., and Younkin, S.G. (1992). Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
115. Sisodia, S.S., Koo, E.H., Beyreuther, K., Unterbeck, A., and Price, D.L. (1990). Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
116. Sisodia, S.S. (1992). β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89, 6075-6079.
117. Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J., and Wight, T.N. (1988). The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
118. Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, P.T., Kimata, K., Koike, Y., and Wight, TN. (1990). Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137, 1253-1270.
119. Snow, A.D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W.A., and Morgan, D.G. (1994). An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 12, 219-234.
120. Snow, A.D., Kinsella, M.G., Parks, E., Sekiguchi, R.T., Miller, J.D., Kimata, K., and Wight, T.N. (1995). Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320, 84-95.
121. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M., and Volk, B. (1992). Detection of interleukin-6 and α-2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
122. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., and Roses, A.D. (1993). Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
123. Stritlmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D., and Roses, A.D. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
124. Suzuki, N., Cheung, T.T., Cai, X.-D., Odaka, A., Otvos, J.L., Eckman, C., Golde, T.E., and Younkin, S.G. (1994). An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336-1340.
125. Tagliavini, F., Ghiso, J., Timmers, W.F., Giaccone, G., Bugiani, O., and Frangione, B. (1990). Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab. Invest. 62, 761-767.
126. Tate-Ostroff, B., Majocha, R.E., and Marotta, C.A. (1989). Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc. Natl. Acad. Sci. USA 86, 745-749.
127. Tienari, P.J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, A., Masters, C.L., Dotti, C.G., and Beyreuther, K. (1997). Intracellular and secreted Alzheimer beta amyloid species are generated by distinct mechanisms in cultured hipocampal neurons. Proc. Natl. Acad. Sci. USA 94, 4125-4130.
128. Tooyama, I., Kimura, H., Akiyama, H., and McGeer, P.L (1990). Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 523, 273-280.
129. 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 8966-8970.
130. Van Nostrand, W.E., Wagner, S.L., Suzuki, M., Choi, B.H., Farrow, J.S., Geddes, J.W., Cotman, C.W., and Cunningham, D.D. (1989). Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor. Nature 341, 546-549.
131. Verbeek, M.M., Otte-Höller, I., Westphal, J.R., Wesseling, P., Ruiter, D.J., and de Waal, R.M.W. (1994). Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. Am. J. Pathol. 144, 104-116.
132. Verbeek, M.M., Otte-Höller, I., Wesseling, P., Van Nostrand, W.E., Sorg, C., Ruiter, D.J., and de Waal, R.M.W. (1995). A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta. Neuropathol. 90, 493-503.
133. Verbeek, M.M., Otte-Höller, I., Wesseling, P., Ruiter, D.J., and de Waal, R.M.W. (1996). Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the Aβ-containing lesions in brains of patients with dementia of the Alzheimer type. Acta. Neuropathol. 91, 608-615.
134. Verbeek, M.M., de Waal, R.M.W., Schipper, J.J., and Van Nostrand, W.E. (1997). Rapid degeneration of cultured human brain pericytes by amyloid β protein. J. Neurochem. 68, 1135-1141.
135. Wang, R., Meschia, J.F., Cotter, R.J., and Sisodia, S.S. (1991). Secretion of the β/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J. Biol. Chem. 266, 16960-16964.
136. Webster, S., O'Barr, S., and Rogers, J. (1994). Enhanced aggregation and structure of amyloid β peptide after coincubation with C1q. J. Neurosci. Res. 39, 448-456.
137. Weidemann, A., König, G., Bunke, D., Fischer, P., Salbaum, J.M., Masters, C.L., and Beyreuther, K. (1989). Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
138. Weidemann, A., Paliga, K., Dürrwang, U., Czech, C., Evin, G., Masters, C.L., and Beyreuther, K. (1997). Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein. Nature Med. 3, 328-332.
139. Westermark, P., Shirahama, T., Skinner, M., Brun, A., Cameron, R., and Cohen, A.S. (1982). Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab. Invest. 46, 457-460.
140. Wisniewski, H.M., Wegiel, J., Wang, K.C., and Lach, B. (1992). Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta. Neuropathol. 84, 117-127.
141. Wisniewski, H.M., and Wegiel, J. (1994). Beta-protein fibrillogenesis and neuritic plaques. In: Neurodegenerative Diseases. D.B. Calne, ed. (Philadelphia USA: W.B. Saunders Co.), pp. 83-95.
142. Yamaguchi, H., Yamazaki, T., Lemere, C.A., Frosch, M.P., and Selkoe, D.J. (1992). Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am. J. Pathol. 141, 249-259.
143. Yamazaki, T., Koo, E.H., and Selkoe, D. (1996). Trafficking of cell-surface amyloid-β-protein precursor. II. Endocytosis, recycling, and lysosomal targeting detected by immunolocalization. J. Cell Sci. 109, 999-1008.
144. Yankner, B.A., Duffy, L.K., and Kirschner, D.A. (1990). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250, 279-282.
145. Zhan, S.-S., Veerhuis, R., Kamphorst, W., and Eikelenboom, P. (1995). Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration. 4, 291-297.